Literature DB >> 7523752

A prospective study of peritoneal transport in CAPD patients.

D G Struijk1, R T Krediet, G C Koomen, E W Boeschoten, F J Hoek, L Arisz.   

Abstract

A prospective two year follow-up study of the functional characteristics of the peritoneal membrane was conducted in 61 CAPD patients. Peritoneal transport of solutes, calculated by mass transfer area coefficients for urea and creatinine, peritoneal clearances for proteins, percentage of absorption of glucose, as well as net ultrafiltration were measured every four months. After five months on CAPD a decrease was found for the transport of most solutes (P < 0.05, mean values, ml/min/1.73 m2): urea 18.1 to 16.2, creatinine 9.5 to 8.4, IgG 0.049 to 0.040 and alpha 2-macroglobulin 0.020 to 0.015, as well as for the absorption of glucose (57.9 to 53.2%, P < 0.05). Net ultrafiltration increased simultaneously from 44.6 to 100.5 ml/4 hr/1.73 m2, P < 0.05. From five months to two years on CAPD a significant increase in the transport of all solutes except alpha 2-macroglobulin was found, as well as a decrease in net ultrafiltration. Peritoneal transport at the end of the study was not significantly different from the starting values. Our findings indicate an initial effect of CAPD itself on peritoneal transport, probably due to the recent start of the treatment. Baseline values were reached after five months on CAPD. Thereafter a gradual increase in peritoneal solute transport occurred during two years of treatment. This can be explained by an increase in the effective peritoneal surface area.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523752     DOI: 10.1038/ki.1994.226

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

1.  The Mutual Relationship Between Peritonitis and Peritoneal Transport.

Authors:  Sadie van Esch; Anouk T N van Diepen; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

2.  The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function.

Authors:  M José Fernández-Reyes; M Auxiliadora Bajo; Gloria Del Peso; Marta Ossorio; Raquel Díaz; Beatriz Carretero; Rafael Selgas
Journal:  Perit Dial Int       Date:  2012-04-02       Impact factor: 1.756

3.  Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.

Authors:  Lynn Redahan; Andrew Davenport
Journal:  J Nephrol       Date:  2015-11-30       Impact factor: 3.902

4.  Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival.

Authors:  Mark Lambie; James Chess; Kieron L Donovan; Yong Lim Kim; Jun Young Do; Hi Bahl Lee; Hyunjin Noh; Paul F Williams; Andrew J Williams; Sara Davison; Marc Dorval; Angela Summers; John D Williams; John Bankart; Simon J Davies; Nicholas Topley
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

Review 5.  Peritoneal Dialysis in Western Countries.

Authors:  Dirk G Struijk
Journal:  Kidney Dis (Basel)       Date:  2015-09-03

6.  The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients.

Authors:  Anouk T N van Diepen; Sadie van Esch; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

7.  Biocompatible Solutions and Long-Term Changes in Peritoneal Solute Transport.

Authors:  Emma H Elphick; Lucy Teece; James A Chess; Jun-Young Do; Yong-Lim Kim; H Bahl Lee; Sara N Davison; Nicholas Topley; Simon J Davies; Mark Lambie
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-31       Impact factor: 8.237

8.  Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis.

Authors:  Herma Uiterwijk; Casper F M Franssen; Johanna Kuipers; Ralf Westerhuis; Ferdau L Nauta
Journal:  Am J Nephrol       Date:  2020-02-18       Impact factor: 3.754

Review 9.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 10.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.